PBH — Prestige Consumer Healthcare Income Statement
0.000.00%
- $3.99bn
- $4.94bn
- $1.13bn
- 88
- 54
- 91
- 92
Annual income statement for Prestige Consumer Healthcare, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 963 | 943 | 1,087 | 1,128 | 1,125 |
Cost of Revenue | |||||
Gross Profit | 561 | 547 | 621 | 625 | 624 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 674 | 658 | 759 | 1,150 | 783 |
Operating Profit | 289 | 285 | 328 | -22.4 | 342 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 191 | 204 | 262 | -93.9 | 276 |
Provision for Income Taxes | |||||
Net Income After Taxes | 142 | 165 | 205 | -82.3 | 209 |
Net Income Before Extraordinary Items | |||||
Net Income | 142 | 165 | 205 | -82.3 | 209 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 142 | 165 | 205 | -82.3 | 209 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.94 | 3.45 | 4.08 | 3.24 | 4.17 |